Critical illness myopathy after COVID-19

Bagnato, Sergio; Boccagni, Cristina; Marino, Giorgio; Prestandrea, Caterina; D’Agostino, Tiziana; Rubino, Francesca

doi:10.1016/j.ijid.2020.07.072

Cited by 77 publications

(97 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Polyneuropathy induced by corticosteroids or other drugs was previously reported in the literature, as was myopathy in critical illness treated in ICU before the pandemic ( Zink et al, 2009 , Yang et al, 2018 ). Some data was published on COVID-19 patients that required admission to the ICU which developed polyneuropathy ( McClafferty et al, 2020 ) and myopathy ( Bagnato et al, 2020 ) associated with the disease. We are already aware of anosmia ( Han et al, 2020 ) and ageusia resulting from direct damage due to the characteristic viral lysis of the neuronal tracts ( Lozada-Nur et al, 2020 ) in COVID-19 patients.…”

Section: Discussionmentioning

confidence: 99%

Nerve conduction study and electromyography findings in patients recovering from Covid-19 – Case report

Daia

Scheau²,

Neagu³

et al. 2021

International Journal of Infectious Diseases

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Nerve conduction study and electromyography findings in patients recovering from Covid-19 – Case report

Daia

Scheau²,

Neagu³

et al. 2021

International Journal of Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…On day 65 of hospitalization, EMG-NCS was consistent with CIP. Another COVID-19 patient showed diffuse and symmetrical muscle weakness after a long stay in ICU [ 117 ]. Her NCS showed normal sensory conduction and low-amplitude compound muscle action potentials; even so, her EMG revealed signs of myopathy that was more pronounced in the lower limbs.…”

Section: Acute Care-related Peripheral Nervous System Complicationsmentioning

confidence: 99%

Peripheral Nervous System Manifestations Associated with COVID-19

Andalib

Biller

Napoli

et al. 2021

Curr Neurol Neurosci Rep

150

110

View full text Add to dashboard Cite

Purpose of Review The present review discusses the peripheral nervous system (PNS) manifestations associated with coronavirus disease 2019 (COVID-19). Recent Findings Nerve pain and skeletal muscle injury, Guillain-Barré syndrome, cranial polyneuritis, neuromuscular junction disorders, neuro-ophthalmological disorders, neurosensory hearing loss, and dysautonomia have been reported as PNS manifestations in patients with COVID-19. Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19. COVID-19 has shown syndromic complexity. Not only does SARS-CoV-2 affect the central nervous system but also it involves the PNS. The PNS involvement may be due to dysregulation of the immune system attributable to COVID-19. Here we review the broad spectrum of PNS involvement of COVID-19.

show abstract

“…In Italy, the case of a 62-year-old female COVID-19 patient who developed diffuse and symmetrical muscle weakness after a long stay in the ICU was followed 60 days after initiating rehabilitation; functional impairment improved except for mild weakness in her lower limb proximal muscles. 6 …”

Section: Postinfectious Pain Associated With Expected Long-term Comentioning

confidence: 99%

Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge

Meyer-Frießem

Gierthmühlen

Baron

et al. 2021

PR9

View full text Add to dashboard Cite

Pain is a common symptom accompanying the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Nonspecific discomfort such as sore throat and body ache are frequent. Parainfectious pain such as headache, myalgia, or neuropathic pain has also been reported. The latter seems to be associated with an autoimmune response or an affection of the peripheral neuromuscular system or the central nervous system because of the viral infection. Furthermore, chronic pain can be a complication of intensive care unit treatment due to COVID-19 itself (such as intensive care-acquired weakness) or of secondary diseases associated with the SARS-CoV-2 infection, including Guillain-Barr é syndrome, polyneuritis, critical illness polyneuropathy, or central pain following cerebrovascular events. Data on long-lasting painful symptoms after clinically manifest COVID-19 and their consequences are lacking. In addition, preexisting chronic pain may be exacerbated by limited and disrupted health care and the psychological burden of the COVID-19 pandemic. Medical providers should be vigilant on pain during and after COVID-19.

show abstract

Critical illness myopathy after COVID-19

Abstract: Highlights Muscle weakness after COVID-19 can be caused by critical illness myopathy. Critical illness myopathy should be suspected in patients with long ICU stay. Health systems must plan access to rehabilitative facilities after COVID-19.

Cited by 77 publications

References 10 publications

Nerve conduction study and electromyography findings in patients recovering from Covid-19 – Case report

Nerve conduction study and electromyography findings in patients recovering from Covid-19 – Case report

Peripheral Nervous System Manifestations Associated with COVID-19

Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge

Contact Info

Product

Resources

About